171 related articles for article (PubMed ID: 19280230)
1. [Correlation between quantitative sensory testing and questionnaires on neuropathic pain for chronic ischemic pain in peripheral arterial disease].
Lang PM; Rüger LJ; Abahji T; Hoffmann U; Crispin A; Irnich D
Schmerz; 2009 Jun; 23(3):251-4, 256-8. PubMed ID: 19280230
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of chronic ischemic pain in patients with peripheral arterial disease.
Rüger LJ; Irnich D; Abahji TN; Crispin A; Hoffmann U; Lang PM
Pain; 2008 Sep; 139(1):201-208. PubMed ID: 18472216
[TBL] [Abstract][Full Text] [Related]
3. [Pain and QST:.."measure what is measurable"...].
Baron R; Tölle TR
Schmerz; 2009 Feb; 23(1):5-6. PubMed ID: 19198887
[No Abstract] [Full Text] [Related]
4. [Procedure for certification of QST laboratories].
Geber C; Scherens A; Pfau D; Nestler N; Zenz M; Tölle T; Baron R; Treede RD; Maier C
Schmerz; 2009 Feb; 23(1):65-9. PubMed ID: 19184121
[TBL] [Abstract][Full Text] [Related]
5. Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities.
Backonja MM; Walk D; Edwards RR; Sehgal N; Moeller-Bertram T; Wasan A; Irving G; Argoff C; Wallace M
Clin J Pain; 2009 Sep; 25(7):641-7. PubMed ID: 19692807
[TBL] [Abstract][Full Text] [Related]
6. Reduced intraepidermal nerve fiber density in patients with chronic ischemic pain in peripheral arterial disease.
Gröne E; Üçeyler N; Abahji T; Fleckenstein J; Irnich D; Mussack T; Hoffmann U; Sommer C; Lang PM
Pain; 2014 Sep; 155(9):1784-1792. PubMed ID: 24931568
[TBL] [Abstract][Full Text] [Related]
7. Validation of a Brazilian quantitative sensory testing (QST) device for the diagnosis of small fiber neuropathies.
Schestatsky P; Stefani LC; Sanches PR; Silva Júnior DP; Torres IL; Dall-Agnol L; Balbinot LF; Caumo W
Arq Neuropsiquiatr; 2011 Dec; 69(6):943-8. PubMed ID: 22297885
[TBL] [Abstract][Full Text] [Related]
8. Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs.
Freeman R; Baron R; Bouhassira D; Cabrera J; Emir B
Pain; 2014 Feb; 155(2):367-376. PubMed ID: 24472518
[TBL] [Abstract][Full Text] [Related]
9. Neurophysiologic and quantitative sensory testing in the diagnosis of trigeminal neuropathy and neuropathic pain.
Jääskeläinen SK; Teerijoki-Oksa T; Forssell H
Pain; 2005 Oct; 117(3):349-357. PubMed ID: 16153774
[TBL] [Abstract][Full Text] [Related]
10. Neuropathic pain: is quantitative sensory testing helpful?
Krumova EK; Geber C; Westermann A; Maier C
Curr Diab Rep; 2012 Aug; 12(4):393-402. PubMed ID: 22623149
[TBL] [Abstract][Full Text] [Related]
11. Sensory neuropathy and signs of central sensitization in patients with peripheral arterial disease.
Lang PM; Schober GM; Rolke R; Wagner S; Hilge R; Offenbächer M; Treede RD; Hoffmann U; Irnich D
Pain; 2006 Sep; 124(1-2):190-200. PubMed ID: 16716518
[TBL] [Abstract][Full Text] [Related]
12. Differences and similarities between atypical facial pain and trigeminal neuropathic pain.
Forssell H; Tenovuo O; Silvoniemi P; Jääskeläinen SK
Neurology; 2007 Oct; 69(14):1451-9. PubMed ID: 17909158
[TBL] [Abstract][Full Text] [Related]
13. Pain ratings at the thresholds are necessary for interpretation of quantitative sensory testing.
Kelly KG; Cook T; Backonja MM
Muscle Nerve; 2005 Aug; 32(2):179-84. PubMed ID: 15937874
[TBL] [Abstract][Full Text] [Related]
14. Chronic ischemic monomelic neuropathy from critical limb ischemia.
Weinberg DH; Simovic D; Isner J; Ropper AH
Neurology; 2001 Sep; 57(6):1008-12. PubMed ID: 11571325
[TBL] [Abstract][Full Text] [Related]
15. Test-retest and interobserver reliability of quantitative sensory testing according to the protocol of the German Research Network on Neuropathic Pain (DFNS): a multi-centre study.
Geber C; Klein T; Azad S; Birklein F; Gierthmühlen J; Huge V; Lauchart M; Nitzsche D; Stengel M; Valet M; Baron R; Maier C; Tölle T; Treede RD
Pain; 2011 Mar; 152(3):548-556. PubMed ID: 21237569
[TBL] [Abstract][Full Text] [Related]
16. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): reference data for the trunk and application in patients with chronic postherpetic neuralgia.
Pfau DB; Krumova EK; Treede RD; Baron R; Toelle T; Birklein F; Eich W; Geber C; Gerhardt A; Weiss T; Magerl W; Maier C
Pain; 2014 May; 155(5):1002-1015. PubMed ID: 24525274
[TBL] [Abstract][Full Text] [Related]
17. Impact of endovascular intervention on pain and sensory thresholds in nondiabetic patients with intermittent claudication: a pilot study.
Lang PM; Vock G; Schober GM; Kramer S; Abahji T; Crispin A; Irnich D; Hoffmann U
J Pain; 2009 Mar; 10(3):264-73. PubMed ID: 19010739
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of laser-evoked potentials and quantitative sensory testing in the diagnosis of neuropathic spinal cord injury pain: a multiple case study.
Landmann G; Berger MF; Stockinger L; Opsommer E
Spinal Cord; 2017 Jun; 55(6):575-582. PubMed ID: 28117333
[TBL] [Abstract][Full Text] [Related]
19. Quantitative sensory testing and mapping: a review of nonautomated quantitative methods for examination of the patient with neuropathic pain.
Walk D; Sehgal N; Moeller-Bertram T; Edwards RR; Wasan A; Wallace M; Irving G; Argoff C; Backonja MM
Clin J Pain; 2009 Sep; 25(7):632-40. PubMed ID: 19692806
[TBL] [Abstract][Full Text] [Related]
20. Reliability and validity of quantitative sensory testing in persons with spinal cord injury and neuropathic pain.
Felix ER; Widerström-Noga EG
J Rehabil Res Dev; 2009; 46(1):69-83. PubMed ID: 19533521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
